Benzinga's Top #PreMarket Gainers

Loading...
Loading...
Celladon Corporation CLDN
shares gained 11.45% to $21.90 in the pre-market trading session. Roth Capital initiated coverage on Celladon with a Buy rating.
Roundy's, Inc.RNDY
shares rose 10.95% to $4.46 in pre-market trading after the company reported stronger-than-expected results for the fourth quarter.
Pharmacyclics Inc.PCYC
shares surged 9.87% to $253.22 in pre-market trading after AbbVie
ABBV
announced its plans to acquire Pharmacyclics for $261.25 per share in cash and stock.
Navidea Biopharmaceuticals, IncNAVB
shares climbed 9.82% to $1.79 in pre-market trading on Q4 results. Navidea Biopharmaceuticals reported a Q3 loss of $0.08 per share on revenue of $2.2 million.
Arrowhead Research Corp. ARWR
gained 9.19% to $8.20 in pre-market trading after the company reported the acquisition of Novartis' entire RNAi research and development portfolio and associated assets.
Posted In: NewsPre-Market OutlookMarketsMoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...